White matter lesions and cognition: It's time for randomized trials to preserve intelligence

Neurology

Volumn 66, Issue 4, 2006, Pages 470-471

  Hill, Michael D ^a   Mitchell, J Ross ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANISOTROPY; BLOOD PRESSURE REGULATION; BRAIN DAMAGE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSION COEFFICIENT; EDITORIAL; HUMAN; INTELLIGENCE; LEUKOARAIOSIS; MORPHOMETRICS; MULTIPLE SCLEROSIS; MYELINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; WHITE MATTER; AGED; BRAIN; CHILD; CONGENITAL MALFORMATION; NOTE; PSYCHOLOGICAL ASPECT;

AGED; BRAIN; CHILD; COGNITION; COGNITION DISORDERS; HUMANS; INTELLIGENCE; RANDOMIZED CONTROLLED TRIALS;

EID: 33645000957     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000203412.56752.88     Document Type: Editorial

References (20)

1. Goldstein IB, Bartzokis G, Guthrie D, Shapiro D. Ambulatory blood pressure and the brain: a 5-year follow-up. Neurology 2005;64:1846-1852.
2. Hill MD, Bisognano JD. Leukoaraiosis: the brain under pressure: target for treatment? Neurology 2005;64:1832-1833.
3. Deary IJ, Bastin ME, Pattie A, et al. White matter integrity and cognition in childhood and old age. Neurology 2006;66:505-512.
4. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 2003;20:1714-1722.
5. Song SK, Yoshino J, Le TQ, et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 2005;26:132-140.
6. Suzuki Y, Matsuzawa H, Kwee IL, Nakada T. Absolute eigenvalue diffusion tensor analysis for human brain maturation. NMR Biomed 2003;16:257-260.
7. Cook LL, Foster PJ, Mitchell JR, Karlik SJ. In vivo 4.0-T magnetic resonance investigation of spinal cord inflammation, demyelination, and axonal damage in chronic-progressive experimental allergic encephalomyelitis. J Magn Reson Imaging 2004;20:563-571.
8. Sled JG, Pike GB. Quantitative imaging of magnetization transfer exchange and relaxation properties in vivo using MRI. Magn Reson Med 2001;46:923-931.
9. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143-156.
10. Coste J, Bouee S, Ecosse E, Leplege A, Pouchot J. Methodological issues in determining the dimensionality of composite health measures using principal component analysis: case illustration and suggestions for practice. Qual Life Res 2005;14:641-654.
11. Deloire MS, Salort E, Bonnet M, et al. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2005;76:519-526.
12. Archibald CJ, Wei X, Scott JN, et al. Posterior fossa lesion volume and slowed information processing in multiple sclerosis. Brain. 2004;127(Pt 7):1526-1534.
13. Denney DR, Lynch SG, Parmenter BA, Horne N. Cognitive impairment in relapsing and primary progressive multiple sclerosis: mostly a matter of speed. J Int Neuropsychol Soc 2004;10:948-956.
14. van Dijk EJ, Breteler MM, Schmidt R, et al. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension 2004;44:625-630.
15. de Leeuw FE, de Groot JC, Oudkerk M, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002;125(Pt 4):765-772.
16. Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003;163:1069-1075.
17. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347-1351.
18. Forette F, Seux ML, Staessen JA, et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002;162:2046-2052.
19. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004;61:1531-1534.
20. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology 2001;56:1539-1545.